北京招聘

?Design and execute in vitro experiments to screen immuno-oncology targets, identify and characterize how the therapeutic leads can modulate immune functions.
?Collaborate with the broader scientific teams to design and execute experiments aimed at defining the mechanism(s) of action.
?Work with in vivo team to develop in vivo models to test the activity of therapeutic leads in combination with established immunotherapeutic agents and perform in-depth characterization of immune responses in these models.
?Engage colleagues in cross-disciplinary scientific discussion, present scientific data to internal and external audiences and keep abreast of relevant scientific literature.
职位要求：
?Ph.D. in the field of immunology, preferably with focus in tumor immunology.
?Post-doctoral or biotech/pharma experience in developing and conducting laboratory research is a plus.
?In-depth knowledge and extensive hands-on experience in primary immune cell characterization and immune-assay development.
?Proven track-record of scientific accomplishment and contributions to the field of cancer immunology.
?Excellent scientific reporting and documentation proficiency.
?The candidate should be an enthusiastic, independent, well-organized and collaborative.

百济神州是一家立足于科学的全球性生物科技公司，专注于开发创新、可负担的药物，旨在为全球患者改善治疗效果，提高药物可及性。目前公司广泛的药物组合包括40多款临床候选药物。公司通过加强自主研发能力和合作，加速推进多元、创新的药物管线开发。我们致力于在2030年前为全球20多亿人全面改善药物可及性。百济神州在全球五大洲打造了一支超过8,000人的团队。